Historically, a positive SLNB necessitated completion ALND to ensure removal of additional cancer that lymph nodes might harbor, said de Boniface. Axillary surgery may lead to multiple arm-related ...
The largest randomized trial of its kind to date found noninferior survival and better arm morbidity among patients with breast cancer who did not undergo completion axillary lymph node dissection.
Green tea is a type of brewed tea with several health benefits. Drinking green tea daily may lower your total and LDL cholesterol levels, reducing your risk of heart disease.
MedPage Today on MSN
Enhanced MRI Tops Ultrasound in Catching Early Liver Cancer
MRI approach also led to fewer false referrals ...
Chlamydia screening increased with a medical assistant directed EMR alert. Read more on the clinical findings.
Five-year OS was 94.4% with ALND omission vs 93.4% with completion ALND (HR 0.89), confirming non-inferiority; breast cancer–specific survival was similarly high in both arms. Inclusion of mastectomy ...
Morning Overview on MSN
A Boston-area trial just showed a single once-a-year shot of an mRNA vaccine pushed pancreatic-cancer patients into remission — built on each tumor’s own gen…
Eight people who had surgery for pancreatic cancer and then received a vaccine built from their own tumor DNA have now gone ...
Morning Overview on MSN
The government just greenlit a daraxonrasib expanded-access program for pancreatic-cancer patients with the KRAS G12C mutation — opening the new targe…
For the roughly 1 to 2 percent of pancreatic-cancer patients whose tumors carry a specific genetic glitch called KRAS G12C, ...
MajesTEC-9 randomized 593 patients (median age 70; median two prior lines) to teclistamab or investigator’s choice PVd or Kd; 80% lenalidomide-refractory, 85% anti-CD38–refractory. Interim analysis ...
Experts from NYU Langone Health's Perlmutter Cancer Center, a National Cancer Institute–designated Comprehensive Cancer Center, present their latest clinical findings and research at the 2026 American ...
Surpass-Early randomized ~800 adults with ≤4-year type 2 diabetes on metformin to add tirzepatide or intensify care, predominantly with semaglutide or dulaglutide comparators. At two years, ...
(NYSE: PFE) today announced detailed results from the pivotal Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results